Podcast Episodes
Back to Search
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics
The last year has demonstrated that a sound financing strategy and compelling company narrative are essential to securing funding – it’s become more …
2 years, 6 months ago
The top life sciences startups to watch this year
Welcome to 2024! This week we're discussing BioSpace's tenth annual list of the hottest new life sciences companies in the U.S. NextGen Class of 2024…
2 years, 6 months ago
What VCs look for when investing with MPM Capital, Endeavor Venture Fund and Two Bear Capital
How can startup leaders support long-term sustainable growth and investment?
BioSpace’s Lori Ellis speaks with venture capital guests Ansbert Gadicke…
2 years, 6 months ago
Every move you make: Biopharma industry under heavy scrutiny
Biden administration flexes regulatory muscles, putting pressure on the biopharma industry over ‘price gouging’ and invoking march-in rights; meanwhi…
2 years, 6 months ago
What VCs really think of the market right now with MPM Capital, Endeavor Venture Fund and Two Bear Capital
What needs to happen for funding in biopharma to bounce back? BioSpace’s Lori Ellis discusses the macroeconomic environment and biopharma funding out…
2 years, 6 months ago
Major FDA approvals for Vertex/CRISPR; bluebird gets black box warning and price scrutiny
That was Week with a capital W. Two major FDA approvals for sickle cell came through on Friday - Casgevy, the first-ever CRISPR-based gene editing th…
2 years, 6 months ago
Fast and furious evolution: How to ensure AI is catalyst for positive societal change with Microsoft and IQVIA
This is the second part of our discussion on the evolution of artificial intelligence and its impact on life sciences with guests from Microsoft and …
2 years, 6 months ago
Integrating AI in life sciences to change employee behavior with Microsoft and IQVIA
Over the last year, the reaction to generative AI has changed - and so have behaviors. People are integrating AI to become more productive and it is …
2 years, 7 months ago
GLP-1 and ADC rollercoasters pick up speed
The weight loss market sees more ups and downs - Altimmune joins the fray and sees a stock jump while Pfizer experiences setbacks; and European Medic…
2 years, 7 months ago
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior
Patient behavior has always had an influence on clinical trials - so how do we contend with missing and/or irregular data now that it is feeding AI m…
2 years, 7 months ago